Small Cap Feast
Small Cap Feast – 09 September 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 880
Total number of AIM Companies trading: 795*
* As at 09 September 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 88*
Total number of NEX Growth Market Companies trading: 86*
* As at 09 September 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 166*
Total number of Standard List Companies trading: 144*
* As at 09 September 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
AMRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019
WORLD HIGH LIFE—The Investment Vehicle is to identify investment opportunities and acquisitions in legal Medicinal Cannabis, Hemp and CBD wellness sectors. The Company has raised £2,398,309 through three issues of Ordinary Shares to private subscribers.
Oncimmune Hldngs (ONC) 92p £57.56m
Oncimmune Holdings plc, a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.
The trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer
Positive results for Early detection of Cancer of the Lung Scotland (“ECLS”) trial presented at the World Conference for Lung Cancer in Barcelona
The ECLS trial, conducted in Scotland with 12,209 patients, is believed to be the largest randomised controlled trial using blood biomarkers for the detection of lung cancer
Further validates the use of Oncimmune’s platform technology as a screening modality, which can detect cancer four years or more before standard clinical diagnosis.
Pennant Int. Group (PEN) 63.5p £23m
Pennant International Group plc the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, announced that on 3 September 2019, at an event at Cranfield University, aviation and aerospace industry leaders and educators came together as a unified body to support the launch of a new Charter for Aviation Skills.
The purpose of this new Charter is to create commitment and responsibility amongst key stakeholders to address the widely-recognised shortage of skilled people within UK aviation industry and to formulate a tangible, and achievable action plan to deliver more trained pilots, aircraft technicians, air traffic controllers and groundcrew.
Organisations attending the Charter event comprised major OEMs, operators and educational institutions and included Airbus, Boeing, British Airways, Ryanair, Leonardo, Marshalls and Cranfield University.
Reabold Resources (RBD) 1.27p £48m
Reabold Resources, the AIM investing company which focuses on investments in pre-cash flow upstream oil and gas projects, notes the announcement made by ADX Energy Ltd today, regarding an update on the drilling of the Iecea Mica-1 appraisal well, located within the Parta license, onshore Romania. Drilling has been completed safely and hydrocarbons have been discovered in multiple zones.
Reabold holds a 37 per cent. equity interest in Danube Petroleum, which has 100% working interest in the sole risk area within the Parta licence that includes IM-1, as well as 50 per cent. of the remainder of the Parta licence. ADX is the operator of the well.
Successful discovery in both the primary target and additional zones, with volumes substantially exceeding pre-drill estimates
Operator volumetrics increased across IM-1 intervals to 20 Bcf of Contingent Resources from 6.1 Bcf of Contingent and 12.7 Bcf Prospective Resources
IM-1 well now being prepared for production testing.
United Oil & Gas (UOG) 4.05p £14m
United Oil & Gas Plc, the London Stock Exchange listed oil and gas exploration and development company, confirms that further to the announcement of 5 June 2019, it has accepted the formal offer from the Oil and Gas Authority, the UK oil and gas regulator, of a 100% interest in Blocks 14/15c, 15/11c, 15/12a, and 15/13c (Licence P2480), with the licence term beginning 15 July 2019. The four highly prospective blocks in the Central North Sea cover an area of c. 500 sq km, and include the Zeta prospect, which United estimates could contain over 90 million barrels of in-place oil. The Blocks, which lie 10km from United’s Crown Discovery, are close to the Marigold and Yeoman discoveries and the substantial Piper, MacCulloch and Claymore oil fields.
Award of Blocks 14/15c, 15/11c, 15/12a, and 15/13c (Licence P2480) to United in UK 31st Licensing Round on a 100% basis
Award in line with United’s European-area strategy to identify and acquire low-risk assets that offer investors near term value trigger opportunities and significant value upside.
SIMEC Atlantis Energy (SAE) 10.25p £44m
SIMEC Atlantis Energy Limited, the global developer, owner and operator of sustainable energy projects, has announced ambitions for a tidal-powered data centre in the Caithness region of Scotland. The power supply for such a data centre would include electricity supplied via a private wire network from tidal turbines at the existing MeyGen project site.
This would be the first ocean powered data centre in the world, with the potential to attract a hyperscale data centre occupier to Scotland. It is expected that the data centre would be connected to multiple international subsea fibre optic cables, offering a fast and reliable connection to London, Europe and the USA. Further connectivity to the central belt using domestic terrestrial networks could significantly improve Scottish data and connectivity resilience.
SimiGon Limited (SIM) 9p £4.5m
SimiGon, Ltd., a global leader in modelling, simulation & training solutions, is announced that its independently operated US subsidiary, SimiGon Inc., has been awarded a United States Air Force contract to provide SIMbox-based F-15E Mixed Reality training devices for USAF Air Combat Command.
The Contract represents further growth in the Company’s MR business portfolio and compliments the strategic path to provide advanced Virtual, Mixed and Augmented training technologies to the USAF and wider Government and Civilian markets. The Contract demonstrates SimiGon’s market penetration into a new, larger customer base, the ACC, the primary supplier of US air combat forces.
Petro Matad (MATD) 8.5p £50.5m
Petro Matad Limited the AIM quoted Mongolian oil explorer, provides the following update on the Heron-1 well in Block XX, eastern Mongolia.
Heron-1 has been drilled to a total depth of 2960 metres with the top Lower Tsagaantsav reservoir, the primary target for the well, encountered at 2803 metres, 5 metres shallower than the pre-drill prognosis. The formation drilled from 2803 to 2880 metres was predominantly sandstone interbedded with shales and siltstones. Oil and gas shows were recorded over this interval and on the basis of the drilling data, the gross reservoir interval in Heron-1 appears to be very similar to the productive reservoirs found in oil wells immediately to the north in Block XIX.
Cerillion (CER) 171p £47m
Cerillion, the billing, charging and customer relationship management software solutions provider, announced a major new contract win worth £3.7m with a telecoms provider in Asia. This latest win, which follows two previously announced wins both reported in June, supports the Company’s existing market forecasts for the current and upcoming financial year.
This initial contract is for the supply and installation of Cerillion’s Enterprise BSS/OSS* Suite, the Company’s pre-integrated end-to-end CRM and billing solution, to support mobile telecoms services, and was awarded after an extensive competitive tender process. This initial phase is expected to be delivered by the end of November 2019, with the contract then likely to be extended to enable the new solution to support fixed-wire services.
Mosman Oil & Gas (MSMN) 0.3p £2.66m
Mosman Oil and Gas Limited the oil exploration, development and production company, advises that the Stanley-3 well in Texas has been completed.
Mosman has been advised that a six foot interval within the 4,800 Sand was perforated during well completion operations. During flow testing, the stabilised rate from this interval was 192 BOPD on an 8/64″ choke. The recovered fluid is 100% oil.
The optimal production rate for this reservoir will be determined by the Operator in due course.
Mosman has a 14.85% working interest in this well.
Mercantile Ports&Log (MPL) 1.6p £27.15m
MPL, which is developing a modern port and logistics facility in Navi Mumbai, Maharashtra, India, announced that its wholly owned subsidiary, Karanja Terminal and Logistics Private Limited has signed a binding contract with Tata Projects part of Tata Group, which is one of India’s oldest and largest global conglomerates, and its joint venture partner Daewoo Engineering and Construction. The Contract is expected to translate into revenue in excess of GBP 5.5 million over a 40-month period starting April 2020. There are provisions in the contract for an extension of an additional 18 months.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.